• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Seattle Genetics, Inc. (SGEN)

    -NasdaqGS
    31.85 Down 1.03(3.13%) Feb 5, 4:00PM EST
    Prev Close:32.88
    Open:32.83
    Bid:30.80 x 200
    Ask:38.17 x 200
    1y Target Est:48.27
    Beta:2.00616
    Next Earnings Date: 9-Feb-16SGEN Earnings announcement
    Day's Range:30.08 - 33.22
    52wk Range:29.31 - 52.33
    Volume:3,317,954
    Avg Vol (3m):1,132,710
    Market Cap:4.44B
    P/E (ttm):N/A
    EPS (ttm):-0.98
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGEN

    Comparison

    Symbol% ChgMkt Cap
    SGENDown 3.13%4.44B
    IMGNDown 4.26%665.15M
    PFEUp 0.10%179.22B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.44
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.95
    Quarterly EPS Est (Dec-15) :-0.20
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-1.99

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback